US 10822608
Oligonucleotide analogues targeting human LMNA
granted A61PA61P43/00
Quick answer
US patent 10822608 (Oligonucleotide analogues targeting human LMNA) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P43/00